Operational Management Committee
The ambitious and passionate founding team is surrounded by complementary experts dedicated to realizing DTAMedical’s ambitions and ensuring VistaCare® becomes the new treatment standard for difficult wounds.
Each member of the DTAMedical team has over 30 years of successful product development experience in the pharmacy, cosmetics, diagnostics and medical device industries. Drawing from this body of experiences, the team continues to create and develop reference tools for Optimized and Less Invasive Wound Treatment, seeking to improve and enhance the quality of life of patients through VistaCare® solution.
François DUFAY, CEO
François Dufaÿ founded DTAMedical in 2010, and currently serving as President.
In addition to his activities as a therapist, François, has also specialized in the lymphatic system, where he teaches and conducts research resulting in several patent applications. In the 2000s, he oriented his career towards commercial industries by actively developing of a generic drug as well as producing and trading cosmetics production both in France and internationally.
In 2009, as the French National winner of innovative Creation-Development technology companies, François sold his assets, and the medical wound treatment device adventure was born, leading to the creation of DTAMedical in 2010.
In 2014, he managed to raise 1 million euros from Cap Innov’Est, to create the VistaCare® system and develop the proof of concept: the VistaCare ONE. DTAMedical is BPI Excellence labelled from 2015.
François holds degrees in physiotherapy and osteopathy, and has been practicing in the wound treatment field for over 30 years, in hospitals and in private sector.
Thierry a renforcé l’équipe DTAMedical début 2018 pour prendre la responsabilité du « Market Access » et des Ventes.
Thierry a plus de 25 ans d’expérience dans le dispositif médical, et plus de 10 années à des postes de direction générale dans le secteur des dispositifs médicaux au sein d’organisations leaders de leurs marchés à hautes concurrences (Boehringer Mannheim, Amersham, WL.Gore Medical, Smith& Nephew), où grâce à la mise en place de nouveaux business models, l’évolution des organisations et cultures, et la recherche de l’excellence opérationnelle, les objectifs ont pu être atteints.
Parmi les nombreux domaines thérapeutiques où Thierry a évolué, il a notamment exercé ces 10 dernières années, des fonctions managériales dans le domaine de la plaie chez Smith & Nephew, puis BSN Medical, en contact permanent avec les clients, de l’hôpital au domicile, des professionnels de santé aux régulateurs, payeurs et associations de patients.
Plus récemment, Thierry a également évolué dans le monde des startups, en étant membre actif de plateformes de crowfunding et au sein de Business Angels Santé, et siège dans des Conseils Administration et Conseils Stratégiques d’associations industrielles au niveau France et Europe (affaires publiques, accès aux marchés, médico-économie) et de start-up.
Thierry a une formation universitaire en Pharmacologie moléculaire complétée par des cursus en Marketing et Direction Générale à l’Essec et I’Insead.
Philippe CHERET, PhD
Director Sales / Marketing & Business Development
Philippe is directly in charge of the operational functions and ensures the link between the development of new ranges and market needs.
With more than 30 years of experience, and knowledge in the field in France and abroad, Philippe has developed five-year strategic plans for organizations small and large companies with double-digit growth across all. He has also opened new market segments and medical concepts and implemented new business plans.
Before joining DTAMedical, Philippe worked in different companies of IVD (In Vitro Diagnosis) and MedTech, successively holding positions in R & D (Diagnostics Pasteur / Sanofi), Sales & Marketing France (Impra Medica / CR-Bard), internationally (CR-Bard, Boston Scientific), and finally as EMEA Director of Strategic Planning & New Business Development & Co-VP South EU (KCI Intl HBV) in the specific field of wound management.
In partnership with complementary experts, Philippe has held consulting assignments for MedTech industries, mainly for missions on “due diligence”.
Since 2017, Philippe is “Expert & Selection Committee Member” within Wilco Healthcare (Paris), and in this context, advises startups.
Philippe holds a PhD in Biochemistry, funded by ANVAR through a patent, and was trained during his career on Business Management at ISG Management – Paris, the in Marketing at Chartered Institute of Marketing of Londres (UK)..
André FOND, PhD, MBA
Dir for R&D & in Charge of QA/RA
André joined DTAMedical in 2014 and is in charge of R&D activities as well as Quality Assurance.
For 15 years, André held managerial positions in R&D and international marketing in major international companies (Hospal, Gambro) in the medical device sector.
He also co-founded and led an innovative company for seven years, which specialized in the analysis of medical optical images. He then co-founded a startup around innovative solutions for real-time imaging of skin for dermatologists.
Throughout his career, André was in charge of the development of several hardware and software products in MedTech, particularly in the areas of electro-medical equipment and medical imaging. Many of these are well-known and used on daily basis by healthcare professionals such as Hospal®, devices of hemodialysis generators sold by GAMBRO group.
André holds a PhD in Biomedical Engineering from UTC and an MBA from EM Lyon.
Jean-François BLOCH, PharmD
Jean-François recently joined the team, and brings expertise in the Intellectual Property strategy.
Jean-François first managed and then directed the Industrial Property and License Agreements department at ORIS group, the biomedical subsidiary of CEA (French Atomic Energy Commission). Afterwards, he co-founded Protéus, a biotechnology company, where he served as Deputy Chief Executive Officer for more than 13 years.
From these experiences, Jean-François founded StartingBloch, consultancy providing bespoke services in the optimization of intellectual property strategy for large and small business.
Jean-François is Doctor of Pharmacy and a graduate of the Center for International Intellectual Property Studies (CEIPI).
Involved to different degrees in the project since 2011, Frédéric has followed the evolution and genesis of DTAMedical. Today, he joins the full-fledged team and brings his expertise to DTAMédical regarding strategy and financial issues.
Closed to the field, in tandem with a professionally training in accounting and financial, Frédéric has a strong experience in the monitoring and development of companies.
Coming from an industrial family, the passion of the company and its development is its engines. From his time in the banking sector, he kept a rigor and a sense of economic and financial balance of a watchmaking precision.
In recent years he has been heavily involved in launching and coaching Start Up’s innovation in the service and industry environment.
Particularly tenacious and present alongside the business leaders he has followed, he has allowed them, often in very tense contexts, to ensure double-digit growth with a controlled financial environment. His action does not stop with his professional activities.
Convinced of the importance of taking environmental and societal issues into account in companies, he is one of the founders of a cooperative for the promotion of CSR (ETRE BFC) and a group of creative consultants (5Impulse) that he knows how to implement, like his network, in the service of the projects he leads.
Moreover, Frédéric is also strongly involved in the development of his territory through activities for which he has implied and engaging mandates (President Initiative Bourgogne Franche Comté – Consular Judge).
Its objectives for DTAMédical remain to integrate development issues in an optimal way with a controlled management of financial resources for the project.
Frédéric is graduated of CNAM, Banking and Financial Engineering specialty.